Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76c49bb84f-h2dfl Total loading time: 0 Render date: 2025-07-05T14:45:26.375Z Has data issue: false hasContentIssue false

Chapter 6 - Deep Brain Stimulation Programming

Fundamentals and Advanced Techniques

Published online by Cambridge University Press:  09 June 2022

By
Leo Verhagen Metman ,
Jessica A. Karl ,
Chandler E. Gill ,
Jens Volkmann  and
Aristide Merola
Edited by
William J. Marks  and
Jill L. Ostrem
William J. Marks
Affiliation:
Stanford University, California
Jill L. Ostrem
Affiliation:
University of California, San Francisco
Get access

Summary

While deep brain stimulation (DBS) for movement disorders is now considered an evidence-based pillar in the management of medication refractory Parkinson’s disease (PD), essential tremor (ET), and dystonia, some healthcare providers remain hesitant to embrace the management of DBS patients because DBS programming is perceived as complicated, time-consuming, and highly technical. Adding to this “intimidation factor” is that in recent years two new manufacturers, Abbott and Boston Scientific, joined pioneer Medtronic in the (US) DBS market in 2016 and 2019, respectively. At first glance, having three different DBS platforms does not seem to simplify matters.

Information

Type
Chapter
Information
Deep Brain Stimulation Management , pp. 58 - 87
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Medtronic (2019). Communicator 8880T2 Technical Manual. M963100A010 Rev B. Minneapolis, MN.Google Scholar
Boston Scientific (2018). VerciseTM Neural Navigator 2.1 Programming Manual: Directions for Use. 92104396–03. Valencia, CA.Google Scholar
Montgomery, E Jr. (2010). Deep Brain Stimulation Programming: Principles and Practice First (Oxford University Press).Google Scholar
Rizzone, M, Lanotte, M, Bergamasco, B, Tavella, A, Torre, E, Faccani, G, Melcarne, A, Lopiano, L (2001). Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: Effects of variation in stimulation parameters. Journal of Neurology Neurosurgery and Psychiatry 71, 215–219.CrossRefGoogle ScholarPubMed
Volkmann, J, Moro, E, Pahwa, R (2006). Basic algorithms for the programming of deep brain stimulation in Parkinson’s disease. Movement Disorders 21, (S14), S284–S289.CrossRefGoogle ScholarPubMed
Moro, E, Esselink, R, Xie, J, Hommel, M, Benabid, A, Pollak, P (2002). The impact on Parkinson’s disease of electrical parameter settings in STN stimulation. Neurology 59, 706–713.CrossRefGoogle ScholarPubMed
Picillo, M, Lozano, AM, Kou, N, Munhoz, RP, Fasano, A (2016). Programming deep brain stimulation for tremor and dystonia: The Toronto Western Hospital algorithms. Brain Stimulation 9, 438–452.CrossRefGoogle ScholarPubMed
Picillo, M, Lozano, AM, Kou, N, Puppi Munhoz, R, Fasano, A (2016). Programming deep brain stimulation for Parkinson’s disease: The Toronto Western Hospital algorithms. Brain Stimulation 9, 425–437.Google Scholar
Koeglsperger, T, Palleis, C, Hell, F, Mehrkens, JH, Bötzel, K (2019). Deep brain stimulation programming for movement disorders: Current concepts and evidence-based strategies. Frontiers in Neurology 10, 410–410.CrossRefGoogle ScholarPubMed
Medtronic Inc. (2015). Patient Programmer 37642 Medtronic® DBSTM Therapy user manual Activa® PC Model 37601 Activa® RC Model 37612 Activa® SC Model 37602 Activa® SC Model 37603. M929532A026. Minneapolis, MN.Google Scholar
Amon, A, Alesch, F (2017). Systems for deep brain stimulation: review of technical features. Journal of Neural Transmission 124, 1083–1091.Google Scholar
Reich, MM, Steigerwald, F, Sawalhe, AD, Reese, R, Gunalan, K, Johannes, S, Nickl, R, Matthies, C, McIntyre, CC, Volkmann, J (2015). Short pulse width widens the therapeutic window of subthalamic neurostimulation. Annals of Clinical and Translational Neurology 2, 427–432.CrossRefGoogle ScholarPubMed
Steigerwald, F, Timmermann, L, Kühn, A, Schnitzler, A, Reich, MM, Kirsch, AD, Barbe, MT, Visser-Vandewalle, V, Hübl, J, Van Riesen, C, et al. (2018). Pulse duration settings in subthalamic stimulation for Parkinson’s disease. Movement Disorders 33.Google Scholar
Dayal, V, Grover, T, Limousin, P, Akram, H, Cappon, D, Candelario, J, Salazar, M, Tripoliti, E, Zrinzo, L, Hyam, J, et al. (2018). The effect of short pulse width settings on the therapeutic window in subthalamic nucleus deep brain stimulation for Parkinson’s disease. Journal of Parkinson’s Disease 8, 273–279.Google Scholar
Timmermann, L, Wojtecki, L, Gross, J, Lehrke, R, Voges, J, Maarouf, M, Treuer, H, Sturm, V, Schnitzler, A (2004). Ten-hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson’s disease. Movement Disorders 19, 1328–1333.Google Scholar
Medtronic Inc. (2019). Medtronic® DBSTM Therapy for Movement Disorders Indication-specific Information for Implantable Neurostimulators: Information for Prescribers Addendum. M939155A046 Rev A. Minneapolis, MN.Google Scholar
Isaias, IU, Alterman, RL, Tagliati, M (2009). Deep brain stimulation for primary generalized dystonia: Long-term outcomes. Archives of Neurology 66, 465–470.Google Scholar
Alterman, RL, Miravite, J, Weisz, D, Shils, JL, Bressman, SB, Tagliati, M (2007). Sixty hertz pallidal deep brain stimulation for primary torsion dystonia. Neurology 69, 681–688.Google Scholar
Temperli, P, Ghika, J, Villemure, JG, Burkhard, PR, Bogousslavsky, J, Vingerhoets, FJG (2003). How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 60, 78–81.CrossRefGoogle ScholarPubMed
Hristova, A, Lyons, K, Troster, A, Pahwa, R, Wilkinson, S, Koller, W (2000). Effect and time course of deep brain stimulation of the globus pallidus and subthalamus on motor features of Parkinson’s disease. Clinical Neuropharmacology 23, 208–211.CrossRefGoogle ScholarPubMed
Levin, J, Krafzcyk, S, Valkovič, P, Eggert, T, Claassen, J, Bötzel, K (2009). Objective measurement of muscle rigidity in Parkinsonian patients treated with subthalamic stimulation. Movement Disorders 24, 57–63.CrossRefGoogle ScholarPubMed
Verhagen Metman, L, Fan, W, Myre, B, Dansen, M, Kartha, N, Arzbaecher, J (2004). Quantification of upper limb bradykinesia in Parkinson’s disease. Neurology 62.Google Scholar
Fasano, A, Helmich, RC (2019). Tremor habituation to deep brain stimulation: Underlying mechanisms and solutions. Movement Disorders 34, 1761–1773.Google Scholar
Deuschl, G, Paschen, S, Witt, K (2013). Clinical outcome of deep brain stimulation for Parkinson’s disease. Handbook of Clinical Neurology 116, 107–128.Google Scholar
Williams, A, Gill, S, Varma, T, Jenkinson, C, Quinn, N, Mitchell, R, Scott, R, Ives, N, Rick, C, Daniels, J, et al. (2010). Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): A randomised, open-label trial. The Lancet Neurology 9, 581–591.Google Scholar
Kleiner-Fisman, G, Herzog, J, Fisman, DN, Tamma, F, Lyons, KE, Pahwa, R, Lang, AE, Deuschl, G (2006). Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes. Movement Disorders 21.Google Scholar
Sriram, A, Foote, KD, Oyama, G, Kwak, J, Zeilman, PR, Okun, MS (2014). Brittle dyskinesia following STN but not GPi deep brain stimulation. Tremor Other Hyperkinet Mov (NY) 4, 242. doi: 10.7916/D8KS6PPR. eCollection 2014CrossRefGoogle Scholar
Ramirez-Zamora, A, Ostrem, JL (2018). Globus pallidus interna or subthalamic nucleus deep brain stimulation for Parkinson disease: A review. JAMA Neurology 75, 367–372.Google Scholar
Oyama, G, Foote, KD, Iyer, SS, Zeilman, P, Hwynn, N, Jacobson, CE, Malaty, IA, Fernandez, HH, Rodriguez, RL, Okun, MS (2011). Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease. Neurologist 17, 282–285.CrossRefGoogle ScholarPubMed
Minguez-Castellanos, A, Escamilla-Sevilla, F, Katati, MJ, Martin-Linares, JM, Meersmans, M, Ortega-Moreno, A, Arjona, V (2005). Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson’s disease: Target related effect or selection bias? Journal of Neurology, Neurosurgery and Psychiatry 76, 34–39.Google Scholar
Fasano, A, Appel-Cresswell, S, Jog, M, Zurowkski, M, Duff-Canning, S, Cohn, M, Picillo, M, Honey, CR, Panisset, M, Munhoz, RP (2016). Medical management of Parkinson’s disease after initiation of deep brain stimulation. Canadian Journal of Neurological Sciences 43, 626–634.CrossRefGoogle ScholarPubMed
Thobois, S, Ardouin, C, Lhommée, E, Klinger, H, Lagrange, C, Xie, J, Fraix, V, Coelho Braga, MC, Hassani, R, Kistner, A, et al. (2010). Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: Predictors and underlying mesolimbic denervation. Brain 133, 1111–1127.Google Scholar
Joshi, R, Bronstein, JM, Keener, A, Alcazar, J, Yang, DD, Joshi, M, Hermanowicz, N (2019). PKG movement recording system use shows promise in routine clinical care of patients with Parkinson’s disease. Frontiers in Neurology 10, 1027. doi: 10.3389/fneur.2019.01027. eCollection 2019Google Scholar
Soh, D, Ten Brinke, TR, Lozano, AM, Fasano, A (2019). Therapeutic window of deep brain stimulation using cathodic monopolar, bipolar, semi-bipolar, and anodic stimulation. Neuromodulation 22, 451–455.CrossRefGoogle ScholarPubMed
Merola, A, Romagnolo, A, Krishna, V, Pallavaram, S, Carcieri, S, Goetz, S, Mandybur, G, Duker, AP, Dalm, B, Rolston, J, et al. (2020). Current directions in deep brain stimulation for Parkinson’s disease: Directing current to maximize clinical benefit [e-pub ahead of print Mar 4 2020]. Neurol Ther. 9(1), 25–41. doi: 10.1007/s40120-020-00181-9. Epub 2020 Mar 9Google Scholar
Ramirez-Zamora, A, Kahn, M, Campbell, J, DeLaCruz, P, Pilitsis, JG (2015). Interleaved programming of subthalamic deep brain stimulation to avoid adverse effects and preserve motor benefit in Parkinson’s disease. Journal of Neurology 262, 578–584.Google Scholar
Hancu, I, Boutet, A, Fiveland, E, Ranjan, M, Prusik, J, Dimarzio, M, Rashid, T, Ashe, J, Xu, D, Kalia, SK, et al. (2019). On the (non-)equivalency of monopolar and bipolar settings for deep brain stimulation fMRI studies of Parkinson’s disease patients. Journal of Magnetic Resonance Imaging 49, 1736–1749.Google Scholar
Lorido, D, Jagid, J, Luca, C (2019). Early experiences with multiple independent current control DBS in Parkinson’s disease. Neurology 92, P1.8–034.CrossRefGoogle Scholar
Butson, CR, McIntyre, CC (2008). Current steering to control the volume of tissue activated during deep brain stimulation. Brain Stimulation 1, 7–15.CrossRefGoogle ScholarPubMed
Weiss, D, Walach, M, Meisner, C, Fritz, M, Scholten, M, Breit, S, Plewnia, C, Bender, B, Gharabaghi, A, Wächter, T, et al. (2013). Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial. Brain 136, 2098–2108.Google Scholar
Valldeoriola, F, Muñoz, E, Rumià, J, Roldán, P, Cámara, A, Compta, Y, Martí, MJ, Tolosa, E (2019). Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson’s disease: A pilot study. Parkinsonism and Related Disorders 60, 153–157.Google Scholar
Castrioto, A, Lozano, AM, Poon, Y-Y, Lang, AE, Fallis, M, Moro, E (2011). Ten-year outcome of subthalamic stimulation in Parkinson disease: A blinded evaluation. Archives of Neurology 68, 1550–1556.Google Scholar
Zibetti, M, Merola, A, Rizzi, L, Ricchi, V, Angrisano, S, Azzaro, C, Artusi, CA, Arduino, N, Marchisio, A, Lanotte, M, et al. (2011). Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Movement Disorders 26, 2327–2334.Google Scholar
Rizzone, MG, Fasano, A, Daniele, A, Zibetti, M, Merola, A, Rizzi, L, Piano, C, Piccininni, C, Romito, LM, Lopiano, L, et al. (2014). Long-term outcome of subthalamic nucleus DBS in Parkinson’s disease: From the advanced phase towards the late stage of the disease? Parkinsonism and Related Disorders 20, 376–381.Google Scholar
Moreau, C, Defebvre, L, Destée, A, Bleuse, S, Clement, F, Blatt, JL, Krystkowiak, P, Devos, D (2008). STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 71, 80–84.CrossRefGoogle ScholarPubMed
Phibbs, FT, Arbogast, PG, Davis, TL (2014). 60-Hz frequency effect on gait in Parkinson’s disease with subthalamic nucleus deep brain stimulation. Neuromodulation 17, 717–720.Google Scholar
Xie, T, Vigil, J, MacCracken, E, Gasparaitis, A, Young, J, Kang, W, Bernard, J, Warnke, P, Kang, U (2015). Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology 84, 415–420.Google Scholar
Sidiropoulos, C, Walsh, R, Meaney, C, Poon, YY, Fallis, M, Moro, E (2013). Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson’s disease. Journal of Neurology 260, 2306–2311.Google Scholar
Moreau, C, Pennel-Ployart, O, Pinto, S, Plachez, A, Annic, A, Viallet, F, Destée, A, Defebvre, L (2011). Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson’s disease. Movement Disorders 26, 659–663.Google Scholar
Xie, T, Bloom, L, Padmanaban, M, Bertacchi, B, Kang, W, MacCracken, E, Dachman, A, Vigil, J, Satzer, D, Zadikoff, C, et al. (2018). Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. Journal of Neurology, Neurosurgery & Psychiatry 89, 989–994.Google Scholar
Merola, A, Zibetti, M, Artusi, CA, Rizzi, L, Angrisano, S, Lanotte, M, Lopiano, L, Rizzone, M G. (2013). 80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: Effects on involuntary movements. Parkinsonism and Related Disorders 19, 453–456.Google Scholar
Kupsch, A, Klaffke, S, Kühn, AA, Meissner, W, Arnold, G, Schneider, GH, Maier-Hauff, K, Trottenberg, T (2003). The effects of frequency in pallidal deep brain stimulation for primary dystonia. Journal of Neurology 250, 1201–1205.Google Scholar
Ostrem, JL, Markun, LC, Glass, GA, Racine, CA, Volz, MM, Heath, SL, de Hemptinne, C, Starr, PA (2014). Effect of frequency on subthalamic nucleus deep brain stimulation in primary dystonia. Parkinsonism & Related Disorders 20, 432–438.CrossRefGoogle ScholarPubMed
Karl, JA, Ouyang, B, Goetz, S, Metman, LV (2020). A novel DBS paradigm for axial features in Parkinson’s disease: A randomized crossover study [published online ahead of print, 2020 Apr 4]. Movement Disorders 35(8), 1369–1378. doi: 10.1002/mds.28048Google Scholar
Karl, JA, Ouyang, B, Verhagen Metman, L (2019). A novel dual-frequency deep brain stimulation paradigm for Parkinson’s disease. Neurology and Therapy 8, 483–489.Google Scholar
Karl, JA, Verhagen Metman, L (2017). A novel deep brain stimulation programming paradigm for essential tremor. Neurology 88, P6.024.Google Scholar
Wodarg, F, Herzog, J, Reese, R, Falk, D, Pinsker, MO, Steigerwald, F, Jansen, O, Deuschl, G, Mehdorn, HM, Volkmann, J (2012). Stimulation site within the MRI-defined STN predicts postoperative motor outcome. Movement Disorders 27, 874–879.Google Scholar
Volkmann, J, Herzog, J, Kopper, F, Geuschl, G (2002). Introduction to the programming of deep brain stimulators. Movement Disorders 17, Suppl. 3, S181–S187. doi: 10.1002/mds.10162Google Scholar
Deuschl, G, Schüpbach, M, Knudsen, K, Pinsker, MO, Cornu, P, Rau, J, Agid, Y, Schade-Brittinger, C (2013). Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson’s disease: Concept and standards of the EARLYSTIM-study. Parkinsonism and Related Disorders 19, 56–61.Google Scholar
Dayal, V, Grover, T, Tripoliti, E, Milabo, C, Salazar, M, Candelario-McKeown, J, Athauda, D, Zrinzo, L, Akram, H, Hariz, M, et al. (2019). Short versus conventional pulse-width deep brain stimulation in Parkinson’s disease: A randomized crossover comparison. Movement Disorders. 35(1), 101–108. doi: 10.1002/mds.27863Google Scholar
Choe, CU, Hidding, U, Schaper, M, Gulberti, A, Köppen, J, Buhmann, C, Gerloff, C, Moll, CKE, Hamel, W, Pötter-Nerger, M (2018). Thalamic short pulse stimulation diminishes adverse effects in essential tremor patients. Neurology 91, e704–e713.Google Scholar
Kirsch, AD, Hassin-Baer, S, Matthies, C, Volkmann, J, Steigerwald, F (2018). Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism and Related Disorders 55, 61–67.Google Scholar
Carl, B, Bopp, M, Saß, B, Waldthaler, J, Timmermann, L, Nimsky, C (2020). Visualization of volume of tissue activated modeling in a clinical planning system for deep brain stimulation. J Neurosurg Sci. doi: 10.23736/S0390-5616.19.04827-6. Online ahead of print.Google Scholar
Zhang, S, Silburn, P, Pouratian, N, Cheeran, B, Venkatesan, L, Kent, A, Schnitzler, A (2019). Comparing current steering technologies for directional deep brain stimulation using a computational model that incorporates heterogeneous tissue properties. Neuromodulation 23(4): 469–477. doi: 10.1111/ner.13031. Epub 2019 Aug 18CrossRefGoogle ScholarPubMed
Press Release (2019). Boston Scientific announces CE mark approval of the VerciseTM Neural Navigator 3 programming software. www.bostonscientific.com/en-EU/news/newsroom-uk/neurological-disorders/press-releases-2019/boston-scientific-announces-ce-mark-approval-of-the-vercise-neural-navigator-3-programming-software.htmlGoogle Scholar
Press Release (2017). Medtronic SureTune3 receives HealthCanada license for deep brain stimulation therapy. www.medtronic.com/ca-en/about/news/surretune3_dbs.htmlGoogle Scholar
Adamchic, I, Hauptmann, C, Barnikol, UB, Pawelczyk, N, Popovych, O, Barnikol, TT, Silchenko, A, Volkmann, J, Deuschl, G, Meissner, WG, et al. (2014). Coordinated reset neuromodulation for Parkinson’s disease: Proof-of-concept study. Movement Disorders 29, 1679–1684.Google Scholar
Wang, J, Nebeck, S, Muralidharan, A, Johnson, MD, Vitek, JL, Baker, KB (2016). Coordinated reset deep brain stimulation of subthalamic nucleus produces long-lasting, dose-dependent motor improvements in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine non-human primate model of parkinsonism. Brain Stimulation 9, 609–617.Google Scholar
Brocker, DT, Swan, BD, Turner, DA, Gross, RE, Tatter, SB, Miller Koop, M, Brontë-Stewart, H, Grill, WM (2013). Improved efficacy of temporally non-regular deep brain stimulation in Parkinson’s disease. Experimental Neurology 239, 60–67.Google Scholar
Jia, F, Guo, Y, Wan, S, Chen, H, Hao, H, Zhang, J, Li, L (2015). Variable frequency stimulation of subthalamic nucleus for freezing of gait in Parkinson’s disease. Parkinsonism and Related Disorders 21, 1471–1472.Google Scholar
Jia, F, Zhang, J, Wang, H, Liang, Z, Liu, W, Wang, X, Liu, Y, Guo, Y, Ling, Z, Cai, X, et al. (2019). Variable-versus constant-frequency deep-brain stimulation in patients with advanced Parkinson’s disease: Study protocol for a randomized controlled trial. Trials 20(1): 749. doi: 10.1186/s13063-019-3884-4Google Scholar
Zauber, SE, Smith, PA, Metman, LV (2015). Fundamentals of deep brain stimulation programming. In Deep Brain Stimulation Management, Marks, WJ Jr., ed. (Cambridge University Press), pp. 64–76.Google Scholar
Cheeran, B, Venkatesan, L, Kent, A (2017). DBS with segmented contacts allows directional control of neural activation. Poster presentation at WSSFN. Berlin, Germany.Google Scholar
Wei, XF, Grill, WM (2005). Current density distributions, field distributions and impedance analysis of segmented deep brain stimulation electrodes. Journal of Neural Engineering 2, 139–147.Google Scholar
Medtronic (2017). Activa® RC 37612 Multi-program Rechargeable Neurostimulator: Implant Manual. M927170A051 Rev A. Minneapolis, MN.Google Scholar
Medtronic (2019). Activa Clinician Programmer Application for Deep Brain Stimulation Programming Guide – Application Version 1.1. M970637A020 Rev A. Minneapolis, MN.Google Scholar
Boston Scientific (2018). VerciseTM Gevia 16 Contact Implantable Pulse Generator: Directions for Use. 92152386–03. Valencia, CA.Google Scholar
Boston Scientific (2018). VerciseTM PC Implantable Pulse Generator: Directions for Use. 92152386–03. Valencia, CA.Google Scholar
Abbott Neuromodulation/St. Jude Medical (2019). St. Jude Medical InfinityTM Implantable Pulse Generator Models 6660, 6661, 6662, 6663: Clinician’s Manual. ARTEN600101496 A. Plano, TX.Google Scholar
Abbott Neuromodulation/St. Jude Medical (2018). Lead and Extension Kits for Deep Brain Stimulation Systems: Clinician’s Manual. ARTEN600008305 A. Plano, TX.Google Scholar
Medtronic, Inc. (2017). DBSTM 3387/3389 Lead Kit for Deep Brain Stimulation: Implant Manual. M927780A035 Rev A. Minneapolis, MN.Google Scholar
Boston Scientific (2018). VerciseTM DBS Leads: Directions for Use. 92104398–01. Valencia, CA.Google Scholar
Medtronic (2017). Reclaim® DBSTM Therapy for OCD: 3391 Lead Kit for Deep Brain Stimulation. M945749A036 Rev B. Minneapolis, MN.Google Scholar
Abbott Neuromodulation/St. Jude Medical (2019). St. Jude MedicalTM Clinician Programmer for DBS Systems Model 3874: Clinician’s Manual. ARTEN600060782 A. Plano, TX.Google Scholar
Medtronic Inc (2019). N’vision® Clinician Programmer with Software 8840 8870. Activa® PC, Activa® RC, and Activa® SC Neurostimulation Systems for Deep Brain Stimulation. 10/10 Programmer Guide for Software Version B. M929531A060. Minneapolis, MN.Google Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×